The aim of this study was to determine the changes in a panel of stromal proteins within the tumor, including THBS1, TNC, FN, SPARC and α-SMA, following neoadjuvant chemotherapy in newly diagnosed breast cancer patients using immunohistochemistry (IHC) staining. The gene discussed is SPARC; the disease is breast cancer.